Table 4.

Incidence rates and incidence rate ratio (with 95% CI) by microorganism isolated for lookback and followup periods in patients with IgA vasculitis (IgAV) and controls.

Lookback PeriodIgAV, n = 314Controls, n = 982IRRp
No.IRNo.IR
  Group A streptococcus50.29 (0.09–0.69)< 50.02 (0.002–0.10)16.1 (2.23–382.9)0.007
  Staphylococcal< 50.24 (0.06–0.61)50.09 (0.003–0.21)2.6 (0.61–10.5)0.28
  H. influenzae0< 50.05 (0.01–0.16)
  Mycoplasma00
  Parainfluenza050.09 (0.003–0.21)
  RSV< 50.18 (0.03–0.52)0
  Adenovirus< 50.12 (0.013–0.43)< 50.02 (0.002–0.21)6.4 (0.48–189.5)0.28
  Viral inducers< 50.12 (0.013–0.0.43)0
  Mycobacterium tub< 50.06 (0.007–0.32)0
  Salmonella00
Followup periodIgAV, n = 492Controls, n = 1236IRRp
No.IRNo.IR
  Group A streptococcus< 50.009 (0.0001–0.052)0
  Staphylococcal240.23 (0.01–0.34)280.08 (0.05–0.13)2.7 (1.55–4.67)< 0.001
  H. influenzae50.047 (0.01–0.09)< 50.003 (0.00004–0.0016)15.7 (2.18–374)0.007
  Mycoplasma< 50.037 (0.01–0.097)20.006 (0.00006–0.021)6.3 (1.2–49.2)0.07
  Parainfluenza110.10 (0.05–0.18)100.03 (0.0014–0.055)3.47 (1.5–8.4)0.009
  RSV00
  Adenovirus070.021 (0.008–0.043)
  Viral inducers< 50.018 (0.002–0.069)0
  Mycobacterium tub00
  Salmonella< 50.018 (0.002–0.069)< 50.003 (0.0004–0.016)6.3 (0.47–185.9)0.29
  • Viral inducers include Epstein-Barr virus, zoster, cytomegalovirus, parvovirus. Small numbers (n < 5) have been confidentialized following HREC requirements. RSV: respiratory syncytial virus; IR: incidence rate; IRR: IR ratio; H. influenzae: Haemophilus influenzae.